Stemming cancer by Hedgehog pathway inhibition: from flies to bedside Fritz AbergerM. Eberl Short Review 14 April 2010 Pages: 3 - 6
Austrian consensus recommendations for the treatment of patients with multiple myeloma E. Gunsiliusfor the myeloma platform of the Austrian Society of Hematology & Oncology (ÖGHO)for the myeloma platform of the Austrian Society of Hematology & Oncology (ÖGHO) Consensus Report 14 April 2010 Pages: 7 - 10
Iron chelation therapy in myelodysplastic syndromes: evidence-based rationale and comparison of guidelines Michael Pfeilstöcker Short Review 14 April 2010 Pages: 11 - 15
Allogeneic stem cell transplantation (SCT) in Ph+ CML: still a therapeutic option? Otto Krieger Short Review 14 April 2010 Pages: 16 - 18
Haemolytic anaemia triggered by antitumoural “biological agents” and immunotherapies with monoclonal antibodies: short review of the literature W. L. SunA. WalderMichael Fiegl Special Report 14 April 2010 Pages: 19 - 22
Fibroblast growth factor receptors (FGFR) as possible therapeutic targets in human non-small cell lung cancer M. GruschWalter Berger Short Review 14 April 2010 Pages: 23 - 26
Biomarkers of angiogenesis and their role in clinical oncology Andreas PircherI. HeideggerW. Hilbe Short Review 14 April 2010 Pages: 27 - 32
Qualitative and quantitative assessment of endpoints in clinical trials Michael A. Fridrik Short Review 14 April 2010 Pages: 33 - 36
Swiss trials in thoracic oncology O. GautschiMiklos Pless Special Report 14 April 2010 Pages: 37 - 40
CECOG’s services at a glance Christoph C. ZielinskiThomas BrodowiczDagmar Just CECOG News 14 April 2010 Pages: 41 - 41